ARCHIVES

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Varmus Wins ASCO’s Science Of Oncology Award; Sawyers To Give Karnofsky Lecture.

January 28, 2005

Murphy Withdraws From SU Position

October 17, 1986

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

October 14, 2005

NCI Community Cancer Centers RFP Issued; Advisors Criticize Project Structure.

November 10, 2006